I didn't mean that. It's simply the timing of the whole thing makes a small retail investor like me wonder.
Teva being on the record for 'deeply getting disappointed' if the approval doesn't come by end of this year. Shows some degree of confidence or may just be a bluff on Teva's part. But the expectation was PPS for MNTA will pick up if no approval is received.